FIGO Vaginal Cancer by Stage
Stage | Description | 5-Year Survival Rate* |
|---|---|---|
I | Limited to the vagina | 75–95% |
II | Invading paravaginal tissues, but not to pelvic sidewall | 50–80% |
III | Extending to the pelvic wall and/or the lower third of the vagina and/or causing hydronephrosis or nonfunctioning kidney; with or without metastases to inguinal lymph nodes | 30–60% |
IV | Extending beyond the true pelvis and/or involving the bladder or rectal mucosa and/or distant metastases (lung or bones); with or without metastases to nearby lymph nodes | 15−50% |
* Prognosis is worse if the primary tumor is large or poorly differentiated. | ||
Based on staging established by the International Federation of Gynecology and Obstetrics (FIGO): Adams TS, Rogers LJ, Cuello MA: Cancer of the vagina: 2021 update. Int J Gynaecol Obstet 155 Suppl 1:19–27, 2021. doi: 10.1002/ijgo.13867 | ||